SPLENDRIS

Live / Registered — Registered (as of 16 Nov 2021)

What this means for you

Registered since 16 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
90389507
Registration number
6559649
Mark type
Word mark
Filed
17 Dec 2020
Published for opposition
31 Aug 2021
Registered
16 Nov 2021
Attorney of record
Nazly Aileen Bayramoglu

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Chemico-pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicines for human purpose, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicated Troches, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of pharmaceutical preparations, which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Medicinal herbal preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biochemical medicines, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases, Pharmaceutical preparations for the treatment of heart rhythm disorders, Synthetic peptides for the treatment of cardiovascular disease; Dietetic substances adapted for medical use, namely, beverages and food in the nature of vitamin, protein, minerals, lecithin, glucose, amino acid, folic acid, fruit juice, fruit oil, honey, seaweed glue, fish oil, cod-liver oil, cubilose, restoratives, plant fibre, nutrition powder, nutrient capsule, nutrient tablets, mineral food-supplements used for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Drugs for medical purposes, namely, Pharmaceutical products for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders

Owner

Prosecution history

  • 16 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
  • 31 Aug 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 31 Aug 2021 — PUBLISHED FOR OPPOSITION
  • 11 Aug 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 28 Jul 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 22 Jul 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 21 Jul 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 21 Jul 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 16 Jun 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 16 Jun 2021 — NON-FINAL ACTION E-MAILED
  • 16 Jun 2021 — NON-FINAL ACTION WRITTEN
  • 11 Jun 2021 — ASSIGNED TO EXAMINER
  • 26 Feb 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 21 Dec 2020 — NEW APPLICATION ENTERED

View this trademark record on Marksy